Trials / Recruiting
RecruitingNCT02918188
Therapeutic Effects of Hydrogen on Steroid-refractory/or Steroid-dependent cGVHD
Therapeutic Effects of Hydrogen on Steroid-refractory/or Steroid-dependent Chronic Graft-versus-host-disease
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 21 (estimated)
- Sponsor
- Navy General Hospital, Beijing · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
This study suggested that hydrogen has a potential as an effective and safe therapeutic agent on cGVHD.
Detailed description
The investigators will evaluate clinical response rate, time to treatment Failure (TTF), overall survival (OS), and toxicity in cGVHD patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hydrogen | Patients will receive hydrogen-rich water orally (500mL three times one day, 0.6mM) |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2026-01-01
- Completion
- 2031-01-01
- First posted
- 2016-09-28
- Last updated
- 2020-07-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02918188. Inclusion in this directory is not an endorsement.